U.S. Retail Pharmacy Market Set to Hit US$ 784.4 Bn by 2031, Key Insights from Persistence Market Research

The U.S. retail pharmacy market is poised for significant growth in the coming years. With an estimated value of US$ 584.1 billion in 2024, the market is projected to reach US$ 784.4 billion by 2031, growing at a CAGR of 4.3% during the forecast period from 2024 to 2031. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, the growing aging population, rising demand for prescription medications, and the expanding range of services offered by retail pharmacies.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/34971

Overview of the U.S. Retail Pharmacy Market

The U.S. retail pharmacy market is a critical part of the healthcare infrastructure, providing essential services and medications to millions of people. The market is fueled by the increasing number of chronic diseases and the rising demand for prescription medications. In particular, chronic conditions such as diabetes, hypertension, and cardiovascular diseases are driving sustained demand for pharmaceuticals. Additionally, the ongoing shift toward home health care, digital health, and the rise of ePharmacies are significantly shaping the landscape.

Retail pharmacies, particularly chains like CVS Health and Walgreens, are not just dispensing medications but also offering a variety of health services, including flu shots, blood pressure monitoring, and telemedicine consultations. Moreover, consumer preferences for convenience are driving the growth of online pharmacies and mail-order services, which are becoming increasingly popular among consumers seeking easy access to healthcare products.

Key Growth Drivers behind the U.S. retail pharmacy market's expansion include:

Rising chronic disease burden, especially among the aging population.

Increasing healthcare spending and a growing preference for over-the-counter (OTC) drugs and home delivery services.

Technological advancements, including AI-driven prescription management systems and ePharmacies.

Growing demand for specialized medications and services such as immunizations, diabetes management, and smoking cessation aids.

The leading segment in the market is the prescription drugs sector, which is expected to hold 54.2% of the market share in 2024. Chronic disease management, particularly for conditions like diabetes and heart disease, plays a central role in this dominance. Additionally, the leading geographical region for retail pharmacies remains the U.S., driven by its advanced healthcare infrastructure, robust healthcare spending, and widespread accessibility of retail pharmacy outlets.

Key Highlights from the U.S. Retail Pharmacy Market Report

✦ In 2024, branded drugs are expected to dominate the market, holding a market share of 67.3%.
✦ Prescription drugs will lead the market with a 54.2% market share in 2024, fueled by the growing incidence of chronic diseases.
✦ The trend toward online pharmacies and mail-order services is accelerating due to consumer demand for convenience and doorstep delivery.
✦ The U.S. retail pharmacy market is growing in response to increasing healthcare spending, especially in the face of rising chronic disease prevalence.
✦ Retail pharmacies are diversifying their services beyond medication dispensing to include flu shots, health monitoring, and other patient care services.
✦ Technological innovations in ePharmacy services and digital prescription management are enhancing patient engagement and operational efficiency.

Market Segmentation

The U.S. retail pharmacy market can be segmented in a variety of ways to better understand the factors contributing to its growth. The market is primarily segmented by product type, end-user, and distribution channels.

By Product Type: The market is broadly categorized into prescription drugs, over-the-counter (OTC) drugs, and generic drugs. Prescription drugs, particularly those for chronic conditions like diabetes and heart disease, dominate the market. Generic drugs are also experiencing significant growth due to their affordability and increasing FDA approvals. The shift towards more cost-effective alternatives has resulted in generic drugs gaining market traction, with generics accounting for 67.3% of the pharmaceutical market in 2024.

By End-User: The retail pharmacy market serves both individual consumers and healthcare facilities. The increasing prevalence of chronic diseases among older adults drives demand from individual consumers, while healthcare facilities rely on retail pharmacies for a wide range of prescription and OTC drugs. As the number of people living with chronic diseases continues to grow, demand from individual consumers will remain high.

By Distribution Channel: Retail pharmacies can be categorized into chain pharmacies, independent pharmacies, and online pharmacies. Chain pharmacies dominate the market, with companies like CVS Health and Walgreens leading the way. However, independent pharmacies are gaining market share by catering to niche consumer bases, while the online pharmacy segment is seeing rapid growth, particularly due to the surge in e-commerce and digital healthcare services.

Regional Insights

The U.S. retail pharmacy market is heavily concentrated in urban areas, with large retail chains such as CVS, Walgreens, and Rite Aid expanding their footprints across the country. However, there is also growing demand in rural and underserved areas, where independent pharmacies play a vital role in providing accessible healthcare services.

The increasing adoption of online pharmacies and mail-order services is particularly evident in metropolitan regions, where digital literacy and internet access are high. Cities like New York, Los Angeles, and Chicago are witnessing robust growth in online pharmacy services. However, the highest penetration of retail pharmacy services is found in the southern and western U.S. regions, driven by both the aging population and the prevalence of chronic conditions in these areas.

Market Drivers

Several key factors are driving the growth of the U.S. retail pharmacy market. The aging population, combined with the rising prevalence of chronic diseases such as diabetes, hypertension, and heart disease, is one of the primary drivers of the market. In 2023, 66% of people in the U.S. used prescription drugs, indicating a strong and growing demand for pharmaceuticals.

Moreover, advancements in technology are also contributing to market growth. The rise of ePharmacies, which provide doorstep delivery of medications, is enhancing the accessibility of pharmaceutical products. As of October 2024, Amazon introduced 24-hour drug delivery in select U.S. cities, further bolstering the trend toward online pharmacies. This shift is expected to grow as more consumers embrace digital health services.

Furthermore, the increasing demand for vaccines, particularly following the COVID-19 pandemic, has led to expanded services in retail pharmacies. More pharmacies are now offering vaccines, immunizations, and other preventive care services, contributing to the market's growth.

Market Restraints

Despite its growth potential, the U.S. retail pharmacy market faces several challenges. Product recalls due to safety concerns or manufacturing defects can significantly harm the reputation of both individual brands and the retail pharmacy sector as a whole. For example, in 2021, Dr. Reddy's Laboratories had to recall batches of Atorvastatin Calcium tablets due to quality issues, which negatively impacted the company's market position.

Additionally, the high cost of healthcare and limited reimbursement options for patients can restrict access to medications, especially for low-income populations. Although generic drugs have become more accessible, high out-of-pocket costs remain a significant barrier for many consumers.

Finally, the growth of counterfeit drugs and illegal pharmacies remains a concern, as they pose risks to patient safety and disrupt the legitimate retail pharmacy market.

Market Opportunities

The U.S. retail pharmacy market holds several promising opportunities for growth. One of the most significant is the rise of online and mail-order pharmacies, which are transforming the way consumers access their medications. With the increasing reliance on smartphones and the internet, more consumers are opting for the convenience of online pharmacies, especially for routine prescription refills.

Another key opportunity lies in the personalized medicine and pharmacogenomics sectors. As healthcare moves toward more tailored treatment options, retail pharmacies are uniquely positioned to deliver personalized pharmaceutical care, especially for chronic conditions like diabetes and cancer. Companies such as CVS Health and Walgreens are already forming partnerships with genomics firms to offer personalized treatments, which will likely become more prevalent in the coming years.

Frequently Asked Questions (FAQs)

How Big is the U.S. Retail Pharmacy Market?
Who are the Key Players in the U.S. Retail Pharmacy Market?
What is the Projected Growth Rate of the U.S. Retail Pharmacy Market from 2024 to 2031?
What is the Market Forecast for the U.S. Retail Pharmacy Market in 2031?
Which Region is Estimated to Dominate the U.S. Retail Pharmacy Market through the Forecast Period?

Company Insights

• CVS Health Corporation
• Walgreens Boots Alliance, Inc.
• Cigna Corporation
• Rite Aid Corporation
• Amazon Pharmacy

Recent Developments:

In 2024, CVS Health expanded its digital capabilities, offering patients a more personalized and efficient healthcare experience.

Walgreens launched a new mobile app in January 2024, improving prescription management features and enhancing customer accessibility.

Conclusion

The U.S. retail pharmacy market is on a steady growth trajectory, driven by an aging population, rising healthcare costs, and increasing demand for both prescription and over-the-counter medications. The rise of ePharmacies and technological innovations presents new opportunities for companies in the sector to reach a broader audience and enhance customer experience. However, challenges such as product recalls, high healthcare costs, and regulatory issues may limit growth potential. Despite these obstacles, the market remains ripe with opportunities, particularly for businesses that innovate and adapt to the growing demand for digital and personalized healthcare services.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.